Biome Diagnostics

Asylia Diagnostics

This company develops an artificial intelligence platform to identify biomarkers and drug targets for precision immunotherapy for pharmaceutical and diagnostic firms.

Oxford Biomarkers

This company develops AI-driven precision diagnostic tests and biomarkers to help clinicians personalise cancer treatments and identify chemotherapy toxicity risks for patients.

Cofactor Genomics

This company develops RNA-based diagnostic tests and predictive immune modelling to help healthcare providers and pharmaceutical researchers identify patient responses to immunotherapy.

CanSense

This company develops blood-based diagnostic tests using laser spectroscopy and artificial intelligence for early-stage bowel cancer detection for healthcare providers and laboratories.

20/20 BioLabs

This company develops AI-powered blood tests for the early detection and prevention of cancers and chronic diseases for individuals and healthcare providers.

InterVenn BioSciences

This company develops glycoproteomic diagnostic tests and an AI-driven analysis platform for clinicians and biopharmaceutical partners to improve disease detection and treatment.

Persona-Dx

The company develops artificial intelligence biomarker tests for tissue and blood samples to help oncologists personalise cancer diagnosis and treatment for metastatic patients.

Ibex Medical

This company develops artificial intelligence software for cancer diagnostics to assist pathologists in labs and hospitals with biopsy analysis and quality control.